Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 11

1.

Low-dose fludarabine and cyclophosphamide combined with standard dose rituximab (LD-FCR) is an effective and safe regimen for elderly untreated patients with chronic lymphocytic leukemia: The Israeli CLL study group experience.

Herishanu Y, Tadmor T, Braester A, Bairey O, Aviv A, Rahimi-Levene N, Fineman R, Levi I, Yuklea M, Ruchlemer R, Shvidel L, Polliack A.

Hematol Oncol. 2019 Apr;37(2):185-192. doi: 10.1002/hon.2580. Epub 2019 Mar 12.

PMID:
30756414
2.

A C5a-Immunoglobulin complex in chronic lymphocytic leukemia patients is associated with decreased complement activity.

Michelis R, Tadmor T, Barhoum M, Shehadeh M, Shvidel L, Aviv A, Stemer G, Dally N, Rahimi-Levene N, Yuklea M, Braester A.

PLoS One. 2019 Jan 2;14(1):e0209024. doi: 10.1371/journal.pone.0209024. eCollection 2019.

3.

Hairy Cell Leukemia: Retrospective Analysis of Demographic Data and Outcome of 203 Patients from 12 Medical Centers in Israel.

Inbar M, Herishanu Y, Goldschmidt N, Bairey O, Yuklea M, Shvidel L, Fineman R, Aviv A, Ruchlemer R, Braester A, Najib D, Rouvio O, Shaulov A, Greenbaum U, Polliack A, Tadmor T.

Anticancer Res. 2018 Nov;38(11):6423-6429. doi: 10.21873/anticanres.13003.

PMID:
30396967
4.

Richter's transformation to diffuse large B-cell lymphoma: a retrospective study reporting clinical data, outcome, and the benefit of adding rituximab to chemotherapy, from the Israeli CLL Study Group.

Tadmor T, Shvidel L, Bairey O, Goldschmidt N, Ruchlemer R, Fineman R, Rahimi-Levene N, Herishanu Y, Yuklea M, Arad A, Aviv A, Polliack A; Israeli CLL Study Group.

Am J Hematol. 2014 Nov;89(11):E218-22. doi: 10.1002/ajh.23826. Epub 2014 Sep 2.

5.

Hodgkin's variant of Richter transformation in chronic lymphocytic leukemia; a retrospective study from the Israeli CLL study group.

Tadmor T, Shvidel L, Goldschmidt N, Ruchlemer R, Fineman R, Bairey O, Rahimi-Levene N, Herishanu Y, Yuklea M, Arad A, Aviv A, Polliack A.

Anticancer Res. 2014 Feb;34(2):785-90.

PMID:
24511013
6.

Significance of bone marrow reticulin fibrosis in chronic lymphocytic leukemia at diagnosis: a study of 176 patients with prognostic implications.

Tadmor T, Shvidel L, Aviv A, Ruchlemer R, Bairey O, Yuklea M, Herishanu Y, Braester A, Rahimi-Levene N, Vernea F, Ben-Ezra J, Bejar J, Polliack A; Israeli CLL Study Group.

Cancer. 2013 May 15;119(10):1853-9. doi: 10.1002/cncr.27930. Epub 2013 Feb 19. Erratum in: Cancer. 2013 Sep 1;119(17):3256. Levene, Naomi [corrrected to Rahimi-Levene, Naomi].

7.

Insect-bite-like reaction in patients with chronic lymphocytic leukemia: a study from the Israeli Chronic Lymphocytic Leukemia Study Group.

Bairey O, Goldschmidt N, Ruchlemer R, Tadmor T, Rahimi-Levene N, Yuklea M, Shvidel L, Berrebi A, Polliack A, Herishanu Y; Israeli Chronic Lymphocytic Leukemia Study Group (ICLLSG).

Eur J Haematol. 2012 Dec;89(6):491-6. doi: 10.1111/ejh.12015. Epub 2012 Oct 26.

PMID:
23033927
8.

Microsatellite instability in patients with chronic B-cell lymphocytic leukaemia.

Niv E, Bomstein Y, Yuklea M, Lishner M.

Br J Cancer. 2005 Apr 25;92(8):1517-23.

9.

Simvastatin induces apoptosis of B-CLL cells by activation of mitochondrial caspase 9.

Chapman-Shimshoni D, Yuklea M, Radnay J, Shapiro H, Lishner M.

Exp Hematol. 2003 Sep;31(9):779-83.

PMID:
12962723
10.

The antiapoptotic effects of blood constituents in patients with chronic lymphocytic leukemia.

Bomstein Y, Yuklea M, Radnay J, Shapiro H, Afanasyev F, Yarkoni S, Lishner M.

Eur J Haematol. 2003 May;70(5):290-5.

PMID:
12694164
11.

Apoptosis as an indicator for steroid sensitivity of lymphocytes in B-chronic lymphocytic-leukemia.

Vishlitzky V, Nessabramof R, Zemer R, Ellis M, Lishner M, Manor Y, Yuklea M, Klein A.

Oncol Rep. 1995 May;2(3):461-3.

PMID:
21597759

Supplemental Content

Loading ...
Support Center